BET1L and amyotrophic lateral sclerosis: Although these ALS rats were confirmed as clinically pre-symptomatic at the point of siRNA injection, the environment in skeletal muscle and at the NMJs may have already been influenced by the ALS mutation, resulting in being more susceptible to Bet1L siRNA (or any treatments) in skeletal muscle.